The Past, Present, and Future of Biopharma M&A
- Queen's Global Markets
- Nov 24, 2023
- 1 min read
This presentation by the Capital Markets team examines the current trends and dynamics in biopharmaceutical mergers and acquisitions. It analyzes the funding lifecycle for drug development, key players, recent deals, current M&A trends, and provides a future outlook for the industry. The presentation also highlights how M&A activity broadly, and within the pharmaceutical industry, has fluctuated in recent years, and explores future drivers such as looming patent cliffs, heightened capital availability, and promising pipeline trends.
Commenti